Nuveen, LLC Dynavax Technologies Corp Transaction History
Nuveen, LLC
- $363 Billion
- Q3 2025
A detailed history of Nuveen, LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Nuveen, LLC holds 381,855 shares of DVAX stock, worth $4.22 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
381,855
Previous 251,286
51.96%
Holding current value
$4.22 Million
Previous $2.49 Million
52.13%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DVAX
# of Institutions
303Shares Held
120MCall Options Held
293KPut Options Held
311K-
Black Rock Inc. New York, NY21.9MShares$242 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT15.7MShares$174 Million4.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.1MShares$89.6 Million0.0% of portfolio
-
State Street Corp Boston, MA6.29MShares$69.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.53MShares$50.1 Million0.02% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.4B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...